Stoke Therapeutics Files 8-K
Ticker: STOK · Form: 8-K · Filed: Aug 11, 2025 · CIK: 1623526
| Field | Detail |
|---|---|
| Company | Stoke Therapeutics, Inc. (STOK) |
| Form Type | 8-K |
| Filed Date | Aug 11, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulation-fd
TL;DR
Stoke Therapeutics filed an 8-K, mostly routine stuff.
AI Summary
On August 11, 2025, Stoke Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates routine corporate reporting by Stoke Therapeutics, Inc. to the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The provided excerpt of the 8-K filing does not contain any specific material events, financial disclosures, or forward-looking statements that would indicate a change in risk.
Key Players & Entities
- Stoke Therapeutics, Inc. (company) — Registrant
- August 11, 2025 (date) — Date of Report
- 001-38938 (other) — Commission File Number
- 47-1144582 (other) — IRS Employer Identification No.
- 45 Wiggins Ave (address) — Principal Executive Offices
- Bedford, Massachusetts (location) — Principal Executive Offices
- 01730 (other) — Zip Code
- (781) 430-8200 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is August 11, 2025.
What is the Commission File Number for Stoke Therapeutics, Inc.?
The Commission File Number for Stoke Therapeutics, Inc. is 001-38938.
Where are Stoke Therapeutics, Inc.'s principal executive offices located?
Stoke Therapeutics, Inc.'s principal executive offices are located at 45 Wiggins Ave, Bedford, Massachusetts, 01730.
What is the IRS Employer Identification Number for Stoke Therapeutics, Inc.?
The IRS Employer Identification Number for Stoke Therapeutics, Inc. is 47-1144582.
Filing Stats: 521 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-08-11 07:00:19
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share STOK Nasdaq Glo
Filing Documents
- d64221d8k.htm (8-K) — 25KB
- d64221dex991.htm (EX-99.1) — 28KB
- 0001193125-25-177433.txt ( ) — 171KB
- stok-20250811.xsd (EX-101.SCH) — 3KB
- stok-20250811_lab.xml (EX-101.LAB) — 17KB
- stok-20250811_pre.xml (EX-101.PRE) — 11KB
- d64221d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated August 11, 2025 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STOKE THERAPEUTICS, INC. Date: August 11, 2025 By: /s/ Thomas E. Leggett Thomas E. Leggett Chief Financial Officer